Hamilton TC - Search Results

1

The role of glutathione in drug resistance.

Ozols RF, O'Dwyer PJ, Hamilton TC, Young RC. Ozols RF, et al. Among authors: hamilton tc. Cancer Treat Rev. 1990 Dec;17 Suppl A:45-50. doi: 10.1016/0305-7372(90)90015-8. Cancer Treat Rev. 1990. PMID: 2092870 Review. No abstract available.

2

Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results.

O'Dwyer PJ, Hamilton TC, Young RC, LaCreta FP, Carp N, Tew KD, Padavic K, Comis RL, Ozols RF. O'Dwyer PJ, et al. Among authors: hamilton tc. J Natl Cancer Inst. 1992 Feb 19;84(4):264-7. doi: 10.1093/jnci/84.4.264. J Natl Cancer Inst. 1992. PMID: 1734088 No abstract available.

3

Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.

Perez RP, O'Dwyer PJ, Handel LM, Ozols RF, Hamilton TC. Perez RP, et al. Among authors: hamilton tc. Int J Cancer. 1991 May 10;48(2):265-9. doi: 10.1002/ijc.2910480219. Int J Cancer. 1991. PMID: 2019469

4

Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems.

Perez RP, Hamilton TC, Ozols RF. Perez RP, et al. Among authors: hamilton tc. Pharmacol Ther. 1990;48(1):19-27. doi: 10.1016/0163-7258(90)90015-t. Pharmacol Ther. 1990. PMID: 2274575 Review.

5

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer.

Schilder RJ, Hall L, Monks A, Handel LM, Fornace AJ Jr, Ozols RF, Fojo AT, Hamilton TC. Schilder RJ, et al. Among authors: hamilton tc. Int J Cancer. 1990 Mar 15;45(3):416-22. doi: 10.1002/ijc.2910450306. Int J Cancer. 1990. PMID: 2307530

6

Multidrug resistance in ovarian cancer.

Fojo A, Hamilton TC, Young RC, Ozols RF. Fojo A, et al. Among authors: hamilton tc. Cancer. 1987 Oct 15;60(8 Suppl):2075-80. doi: 10.1002/1097-0142(19901015)60:8+<2075::aid-cncr2820601521>3.0.co;2-f. Cancer. 1987. PMID: 3308067 Review.

7

Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO.

Gallo JM, Brennan J, Hamilton TC, Halbherr T, Laub PB, Ozols RF, O'Dwyer PJ. Gallo JM, et al. Among authors: hamilton tc. Cancer Res. 1995 Oct 15;55(20):4507-11. Cancer Res. 1995. PMID: 7553617 Clinical Trial.

8

Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs.

O'Dwyer PJ, Hamilton TC, Yao KS, Tew KD, Ozols RF. O'Dwyer PJ, et al. Among authors: hamilton tc. Hematol Oncol Clin North Am. 1995 Apr;9(2):383-96. Hematol Oncol Clin North Am. 1995. PMID: 7642469 Review.

9

Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.

Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC. Yao KS, et al. Among authors: hamilton tc. Cancer Res. 1995 Oct 1;55(19):4367-74. Cancer Res. 1995. PMID: 7671249

10

Mechanisms and modulation of resistance to chemotherapy in ovarian cancer.

Perez RP, Hamilton TC, Ozols RF, Young RC. Perez RP, et al. Among authors: hamilton tc. Cancer. 1993 Feb 15;71(4 Suppl):1571-80. doi: 10.1002/cncr.2820710424. Cancer. 1993. PMID: 8094321 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page